Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Susan Otawa"'
Autor:
Emmanouil Rampakakis, John S Sampalis, Susan Otawa, Proton Rahman, Michel Zummer, Andrew Chow, May Shawi, Majed Khraishi, Denis Choquette, William G Bensen, Saeed Shaikh, Maqbool Sheriff, Sanjay Dixit, Dalton Sholter, Eliofotisti Psaradellis, Vincent Letourneau, Allen J Lehman, François Nantel
Publikováno v:
BMJ Open, Vol 6, Iss 4 (2016)
Objectives To describe the profile of patients with ankylosing spondylitis (AS) treated with infliximab in Canadian routine care and to assess the effectiveness and safety of infliximab in real world.Setting 46 primary care rheumatology practices acr
Externí odkaz:
https://doaj.org/article/d179726233ae4da69c959a990fa648ba
Autor:
Amanda Quebe, Bochao Jia, Zhanguo Li, Guillermo J. Valenzuela, Kirstin Griffing, Alvin F. Wells, Edward C. Keystone, Li Xie, Boulos Haraoui, Susan Otawa
Publikováno v:
Rheumatology and Therapy
Introduction To evaluate long-term efficacy of once-daily baricitinib 2 mg in patients with active rheumatoid arthritis who had an inadequate response (IR) to conventional synthetic disease-modifying antirheumatic drugs (csDMARD) or biologic DMARDs (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0c31c962c0e5939e79b56b6879b7af9
https://doi.org/10.1007/s40744-021-00317-9
https://doi.org/10.1007/s40744-021-00317-9
Autor:
Rena Klar, Terence Rooney, Mark C. Genovese, William L. Macias, Josef S Smolen, Boulos Haraoui, Inmaculada de la Torre, Li Xie, Ana Pinto-Correia, Pedro Lopez-Romero, Susan Otawa, Tsutomu Takeuchi, Zhanguo Li
Publikováno v:
Annals of the Rheumatic Diseases. 78:171-178
ObjectivesThis study investigated the effects of dose step-down in patients with rheumatoid arthritis (RA) who achieved sustained disease control with baricitinib 4 mg once a day.MethodsPatients who completed a baricitinib phase 3 study could enter a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6b2e3f2b845caf53c367ba2d2d5fa59
https://doi.org/10.1136/annrheumdis-2018-213271
https://doi.org/10.1136/annrheumdis-2018-213271
Autor:
Carol L. Gaich, Janet E. Pope, Amy M. DeLozier, Amanda Quebe, Luna Sun, Clifton O. Bingham, Susan Otawa
Publikováno v:
THURSDAY, 14 JUNE 2018.
Background Fatigue and pain in patients (pts) with RA are often measured with the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) and the Medical Outcomes Study Short-Form-36 (SF-36). Patient-Reported Outcomes Measurement Informati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46e47e67003bf5c02d7dd796bf9b54a9
https://doi.org/10.1136/annrheumdis-2018-eular.1890
https://doi.org/10.1136/annrheumdis-2018-eular.1890
Autor:
Luna Sun, Amy M. DeLozier, Janet E. Pope, Carol L. Gaich, Susan Otawa, Clifton O. Bingham, Amanda Quebe
Publikováno v:
FRIDAY, 15 JUNE 2018.
Background In patients (pts) with RA, physical function (PF) can be measured with the Health Assessment Questionnaire-Disability Index (HAQ-DI). Patient-Reported Outcomes Measurement Information System (PROMIS) was developed by the National Institute
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d9f702617b1efc3eb0bc0b63bb56624
https://doi.org/10.1136/annrheumdis-2018-eular.2001
https://doi.org/10.1136/annrheumdis-2018-eular.2001
Autor:
Jane Barry, Andrea Rubbert-Roth, Thorsten Holzkämper, Dalia Unikiene, Inmaculada de la Torre, Jean Dudler, Susan Otawa, Edward C. Keystone, Peter C. Taylor, N. Bello, Rasa Kausiene, Frederick Durand, R.B. Alonso, Juan Sanchez Burson, Esbjörn Larsson, Regina Cseuz, Edit Drescher, Zdeněk Dvořák, D. Andersone, I. Irto, Stephanie de Bono, Bernard Combe, A Ghizdavescu, Marek Krogulec, Anna Dudek
Publikováno v:
Rheumatology. 56
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06657dafa7f6369115cbd63d733515f9
https://doi.org/10.1093/rheumatology/kex061.001
https://doi.org/10.1093/rheumatology/kex061.001
Autor:
Jörn Kekow, Georg Pum, Inmaculada de la Torre, Omid Zamani, Piet Geusens, Hasan Tahir, Susan Otawa, Patrick Durez, Veronica Rogai, Inger Gjertsson, Soyi Liu Leage, Piercarlo Sarzi Puttini, Esbjörn Larsson, Subhashini Arthanari, Dario Roccatello, S. Shaikh, David Walker, Thorsten Holzkämper, Filip Van den Bosch, Ivaylo Stoykov
Publikováno v:
Rheumatology. 56
Background: Baricitinib, an oral JAK1/JAK2 inhibitor, improves disease activity with an acceptable safety profile in patients with active rheumatoid arthritis (RA). We report efficacy and safety data for baricitinib as monotherapy or in combination w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba597cc5b6e0940b7d894eabcf3cd622
https://doi.org/10.1093/rheumatology/kex062.217
https://doi.org/10.1093/rheumatology/kex062.217
Autor:
P. Taylor, S. de Bono, D. Andersone, N. Bello, Z. Dvořák, A Ghizdavescu, L.F. Gonçalves, Anna Dudek, I. de la Torre, Esbjörn Larsson, Andrea Rubbert-Roth, Juan Sanchez Burson, Susan Otawa, Thorsten Holzkämper, R.B. Alonso, B. Combe, E.C. Keystone, I. Irto, Regina Cseuz, Jean Dudler, Marek Krogulec, Frederick Durand, E. Drescher, D. Unikiene, Jane Barry, R. Kausiene
Publikováno v:
Revista Brasileira de Reumatologia. 57:S380-S381
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ce2479d99b7996820587be4f539b444
https://doi.org/10.1016/j.rbr.2017.07.536
https://doi.org/10.1016/j.rbr.2017.07.536
Autor:
Carter, Thorne, William G, Bensen, Denis, Choquette, Andrew, Chow, Majed, Khraishi, Christopher J, Atkins, John T, Kelsall, Allen J, Lehman, May, Shawi, Hayssam, Khalil, Francois, Nantel, Emmanouil, Rampakakis, John S, Sampalis, Susan, Otawa
Publikováno v:
Arthritis careresearch. 66(8)
To describe the profile of rheumatoid arthritis (RA) patients treated with infliximab in Canadian routine care and to assess the real-world effectiveness and safety of infliximab.Biologics-naive RA patients from the Biologic Treatment Registry Across
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d09defe26db6d793774c9926b6915e32
https://pubmed.ncbi.nlm.nih.gov/24470077
https://pubmed.ncbi.nlm.nih.gov/24470077